Diferencia entre revisiones de «Amantadine»
Sin resumen de edición |
(Switch SMW query from broadtable to table format for better layout with TOC) |
||
| (No se muestran 4 ediciones intermedias de 3 usuarios) | |||
| Línea 53: | Línea 53: | ||
==Pharmacology== | ==Pharmacology== | ||
*Half-life: 10-25h | *Half-life: 10-25h | ||
*Metabolism: | *Metabolism: Not appreciably metabolized; small amounts of acetyl metabolite identified | ||
*Excretion: Renal | *Excretion: Renal | ||
| Línea 61: | Línea 61: | ||
==Comments== | ==Comments== | ||
==Indications by Condition== | |||
''The following table is automatically generated from disease/condition pages across WikEM.'' | |||
{{#ask:[[Has DrugName::Amantadine]] | |||
|?Has Indication=Indication | |||
|?Has Dose=Dose | |||
|?Has Context=Context | |||
|?Has Route=Route | |||
|?Has Population=Population | |||
|format=table | |||
|headers=plain | |||
|mainlabel=- | |||
|sort=Has Indication | |||
|limit=50 | |||
}} | |||
==See Also== | ==See Also== | ||
| Línea 68: | Línea 85: | ||
<references/> | <references/> | ||
[[Category:Pharmacology]] | [[Category:Pharmacology]] [[Category:ID]] [[Category:Neurology]] | ||
Revisión actual - 21:57 20 mar 2026
Administration
- Type: Antiviral, anticholinergics
- Dosage Forms: capsule or tablet, syrup
- Routes of Administration: Oral
- Common Trade Names: Gocovri
Adult Dosing
Influenza A
- 100 mg BID or 200 mg daily PO
Parkinsonism, extrapyramidal disease
- 100-200 mg BID
Neuroleptic malignant syndrome
- 100mg PO initially
- Titrate up as needed to max dose 200mg q12hr
Pediatric Dosing
Influenza, 1-9 years old
- 2.2-4.4 mg/kg PO BID
Influenza, >9 years old
- 100 mg PO BID
Special Populations
- Pregnancy Rating: C
- Lactation risk: Infant risk cannot be ruled out
- Renal dosing:
- CrCl 30-50 mL/min: 200 mg PO on first day, then 100 mg/day
- CrCl 15-29 mL/min: 200 mg PO on first day, then 100 mg every other day
- CrCl <15 mL/min or on HD: 200mg weekly
- Hepatic dosing: not defined
Contraindications
- Allergy to class/drug
Adverse Reactions
Serious
- CHF, hypotension, dysrhythmia, tachycardia, cardiac arrest
- Pulmonary edema, acute respiratory failure
- Malignant melanoma
- Leukopenia, agranulocytosis, neutropenia
- Neuroleptic malignant syndrome
- Suicidal ideation
Common
- Nausea, diarrhea, constipation, lack of appetite
- Headache
- Fatigue, dizziness, confusion, ataxia
- Anxiety, insomnia, depression, irritability, hallucinations, dream disorder
- Orthostatic hypotension
- Peripheral edema
Pharmacology
- Half-life: 10-25h
- Metabolism: Not appreciably metabolized; small amounts of acetyl metabolite identified
- Excretion: Renal
Mechanism of Action
- Interferes with the function of viral M2 protein, preventing release of viral nucleic acids into host cell
Comments
Indications by Condition
The following table is automatically generated from disease/condition pages across WikEM.